Could Prior COVID-19 Affect the Neutralizing Antibody after the Third BNT162b2 Booster Dose: A Longitudinal Study
Vaccination is an essential public health measure for preventing the spread of illness during this continuing COVID-19 epidemic. The immune response developed by the host or the continuation of the immunological response caused by vaccination is crucial since it might alter the epidemic’s prognosis....
Main Authors: | Mustafa Genco Erdem, Ozge Unlu, Suleyman Buber, Mehmet Demirci, Bekir Sami Kocazeybek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/3/560 |
Similar Items
-
A Longitudinal Study in Turkiye of Host Ability to Produce Antibodies following a Third Homologous BNT162b2 Vaccination
by: Mustafa Genco Erdem, et al.
Published: (2023-03-01) -
Comparison of SARS-CoV-2 Antibody Levels after a Third Heterologous and Homologous BNT162b2 Booster Dose
by: Nesrin Gareayaghi, et al.
Published: (2022-10-01) -
Waning of Humoral Immunity and the Influencing Factors after BNT162b2 Vaccination: A Cohort Study with a Latent Growth Curve Model in Fukushima
by: Yurie Kobashi, et al.
Published: (2022-11-01) -
Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)
by: Maria Antonietta Isgrò, et al.
Published: (2022-07-01) -
Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection
by: Federico Gobbi, et al.
Published: (2021-03-01)